P&G sued after FDA panel finds oral phenylephrine, active ingredient in DayQuil, doesn’t work


The FDA panel said oral phenylephrine, the decongestant in DayQuil, is thoroughly ineffective.

Previous Exclusive: Lankford Wade, new CEO of Greensboro startup UpStream, plans to add 100 employees within a year
Next Brickline Greenway will build on region's strengths, connections | Opinion